Pharmacokinetics of cefamandole in patients undergoing hemodialysis and peritoneal dialysis
- PMID: 984787
- PMCID: PMC429770
- DOI: 10.1128/AAC.10.3.457
Pharmacokinetics of cefamandole in patients undergoing hemodialysis and peritoneal dialysis
Abstract
The pharmacokinetics of cefamandole nafate, a new parenteral cephalosporin derivative, were evaluated in 11 patients with chronic renal failure (creatinine clearance less than 5 ml/min), including five patients during hemodialysis, four patients during routine peritoneal dialysis, and two patients during the interdialytic period. Peak serum levels of cefamandole were comparable to those observed in patients with normal renal function. Clearance of the drug during the interdialytic period and during hemodialysis and peritoneal dialysis was minimal, with a resultant significant prolongation of serum half-life. The nondialyzability of cefamandole is in contrast with reported studies of cephalothin, where significant reduction of the serum half-life was achieved during hemodialysis but not peritoneal dialysis. The concentration of cefamandole in the peritoneal dialysate after parenteral administration was observed to be bactericidal for many gram-negative pathogens and, with the exception of Streptococcus faecalis, most gram-positive organisms found in bacterial peritonitis in patients with severe renal failure. The present data suggest that if stable bactericidal serum levels of cefamandole are to be maintained during hemodialysis and peritoneal dialysis, a parenteral loading dose must be administered followed by one-half the loading dose every half-life.
Similar articles
-
Pharmacokinetics of cefamandole in patients with renal failure.Antimicrob Agents Chemother. 1977 Feb;11(2):248-50. doi: 10.1128/AAC.11.2.248. Antimicrob Agents Chemother. 1977. PMID: 848929 Free PMC article.
-
Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokinetics.Kidney Int. 1984 Sep;26(3):308-18. doi: 10.1038/ki.1984.174. Kidney Int. 1984. PMID: 6542606 Clinical Trial.
-
Pharmacokinetics of cefamandole in the presence of renal failure in patients undergoing hemodialysis.Antimicrob Agents Chemother. 1976 Oct;10(4):623-5. doi: 10.1128/AAC.10.4.623. Antimicrob Agents Chemother. 1976. PMID: 984799 Free PMC article.
-
Pharmacokinetics of cephalosporins in patients with normal or reduced renal function.J Infect Dis. 1978 May;137 Suppl:S88-S99. doi: 10.1093/infdis/137.supplement.s88. J Infect Dis. 1978. PMID: 349098 Review.
-
A review and summary of the pharmacokinetics of cefoperazone: a new, extended-spectrum beta-lactam antibiotic.Ther Drug Monit. 1981;3(2):121-8. doi: 10.1097/00007691-198102000-00002. Ther Drug Monit. 1981. PMID: 6455787 Review.
Cited by
-
Disposition kinetics of cefamandole during continuous ambulatory peritoneal dialysis.Antimicrob Agents Chemother. 1986 Apr;29(4):649-53. doi: 10.1128/AAC.29.4.649. Antimicrob Agents Chemother. 1986. PMID: 3707113 Free PMC article.
-
Clinical pharmacokinetics of antibiotics in patients with impaired renal function.Clin Pharmacokinet. 1992 Mar;22(3):169-210. doi: 10.2165/00003088-199222030-00002. Clin Pharmacokinet. 1992. PMID: 1559311 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources